Christopher M. Smith, Chairman and CEO at Ortho Clinical Diagnostics Holdings plc (OCDX), sold 100,000 shares at $21.10 ($2.1M) on 2022-01-03, disclosed to the SEC on 2022-01-05.
Open-market sale of $2.1M OCDX by Chairman and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |